• EN

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    A Look At CBIZ (CBZ) Valuation As Lawsuit Over Alleged Understated AmeriTex Valuation Proceeds

    Simply Wall St·04/06/2026 16:18:56
    Listen to the news

    CBIZ (CBZ) is back in focus after a federal judge declined to halt a lawsuit tied to an allegedly understated AmeriTex valuation, clearing the way for full discovery into claimed intentional breaches of duty.

    See our latest analysis for CBIZ.

    The legal setback has come at a time when momentum in CBIZ's share price has been weak. The 1 day share price return is 4.43%, the year to date share price return reflects a 45.65% decline, and the 1 year total shareholder return shows a 61.11% loss. This suggests that recent volatility is occurring alongside a longer period of pressure on shareholders.

    If this legal risk has you reassessing your options, it may be worth widening your research to other opportunities using the 20 top founder-led companies

    With CBIZ trading at $27.61 and data pointing to a sizable gap versus some valuation estimates, investors now face a key question: is the stock mispriced after heavy losses, or is the market already accounting for its future prospects?

    Most Popular Narrative: 37.7% Undervalued

    CBIZ's most followed narrative points to a fair value of about $44.33 per share, compared with the last close at $27.61. This frames a sizable valuation gap that rests on execution and capital allocation.

    The Marcum acquisition has significantly expanded CBIZ's client base, increased scale, and strengthened capabilities in core tax, accounting, and advisory services, enabling the firm to leverage cross-selling, deepen client relationships, and improve its competitive position in target middle-market segments; this is expected to fuel higher future revenue growth and structural margin expansion as integration synergies are realized.

    Read the complete narrative.

    Curious what sits behind that confidence in higher revenue, fatter margins, and a bigger earnings base, all discounted back at a specific required return? The full narrative explains how steady top line expansion, improving profitability and a future earnings multiple fit together to justify that fair value, and how much share count change is assumed along the way.

    Result: Fair Value of $44.33 (UNDERVALUED)

    Have a read of the narrative in full and understand what's behind the forecasts.

    However, that upside story can quickly unravel if pricing pressure persists or if ongoing integration and leverage from the Marcum deal weigh more heavily on margins.

    Find out about the key risks to this CBIZ narrative.

    Next Steps

    With mixed sentiment around CBIZ's valuation and legal overhang, it makes sense to move fast: review the underlying numbers yourself and weigh both sides of the story using the 4 key rewards and 3 important warning signs

    Looking for more investment ideas?

    Do not stop with one stock under pressure. Broaden your watchlist with focused ideas that match different goals and risk levels using these hand picked screeners.

    This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.